Cargando…

Dual-Positive MPO- and PR3-ANCA-Associated Vasculitis Following SARS-CoV-2 mRNA Booster Vaccination: A Case Report and Systematic Review

As the coronavirus disease 2019 (COVID-19) pandemic is ongoing, and new variants of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are emerging, vaccines are needed to protect individuals at high risk of complications and to potentially control disease outbreaks by herd immunity....

Descripción completa

Detalles Bibliográficos
Autores principales:	Baier, Eva, Olgemöller, Ulrike, Biggemann, Lorenz, Buck, Cordula, Tampe, Björn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148036/ https://www.ncbi.nlm.nih.gov/pubmed/35632410 http://dx.doi.org/10.3390/vaccines10050653

Ejemplares similares

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2021)

Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity
por: Baier, Eva, et al.
Publicado: (2022)

pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2022)

Infection is associated with increased risk of MPO- but not PR3-ANCA-associated vasculitis
por: Rathmann, Jens, et al.
Publicado: (2022)

Kinetics of human leukocyte antigen receptor HLA-DR(+) monocytes and T lymphocytes during remission induction therapy in ANCA-associated vasculitis
por: Tampe, Désirée, et al.
Publicado: (2022)

A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination
por: Kim, Beop Chang, et al.
Publicado: (2022)

Low levels of hemoglobin associate with critical illness and predict disease course in patients with ANCA-associated renal vasculitis
por: Baier, Eva, et al.
Publicado: (2022)

Comparative analysis of complement C3 and C4 serum levels for outcome prediction in ANCA-associated renal vasculitis
por: Tampe, Désirée, et al.
Publicado: (2022)

Relevance of Complement C4 Deposits Localized to Distinct Vascular Compartments in ANCA-Associated Renal Vasculitis
por: Hakroush, Samy, et al.
Publicado: (2022)

Leukocyturia and hematuria enable non-invasive differentiation of Bowman’s capsule rupture severity in PR3-ANCA glomerulonephritis
por: Baier, Eva, et al.
Publicado: (2022)

MPO-ANCA associated vasculitis with mononeuritis multiplex following influenza vaccination
por: Eindhoven, Stefanie, et al.
Publicado: (2017)

POS-851 MPO-ANCA ASSOCIATED VASCULITIS AFTER COVID-19
por: GARCIA-VEGA, A., et al.
Publicado: (2022)

C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis
por: Korsten, Peter, et al.
Publicado: (2023)

Double-Positive Anti-GBM and ANCA-MPO Vasculitis Presenting With Crescentic Glomerulonephritis
por: Pacheco, Mariana, et al.
Publicado: (2021)

Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis
por: Sethi, Amit, et al.
Publicado: (2023)

Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
por: Ekman, Diana, et al.
Publicado: (2023)

Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study
por: Ozaki, Shoichi, et al.
Publicado: (2011)

Alpha-1 Antitrypsin Deficiency Presenting with MPO-ANCA Associated Vasculitis and Aortic Dissection
por: Voorzaat, Bram M., et al.
Publicado: (2017)

Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?
por: O'Sullivan, Kim M., et al.
Publicado: (2021)

Low hemoglobin levels are associated with Bowman’s capsule rupture and peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular injury to anemia?
por: Baier, Eva, et al.
Publicado: (2023)

Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA
por: Dahlqvist, Johanna, et al.
Publicado: (2021)

The role of myeloperoxidase and myeloperoxidase–antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis
por: Arimura, Yoshihiro, et al.
Publicado: (2013)

A Case of Concurrent MPO-/PR3-Negative ANCA-Associated Glomerulonephritis and Membranous Glomerulopathy
por: Nakada, Yasuyuki, et al.
Publicado: (2015)

PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease
por: Chen, Dhruti P., et al.
Publicado: (2023)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study
por: van Eeden, Charmaine, et al.
Publicado: (2023)

Neutrophils associate with Bowman’s capsule rupture specifically in PR3-ANCA glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2021)

Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies
por: O’Brien, Eóin C., et al.
Publicado: (2015)

MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
por: Obata, Shota, et al.
Publicado: (2021)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
por: Baldallo, Cinthia, et al.
Publicado: (2021)

MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits
por: Matsumoto, Kei, et al.
Publicado: (2009)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination
por: Hakroush, Samy, et al.
Publicado: (2021)

Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series
por: Caroti, L., et al.
Publicado: (2019)

From Kidney to Brain: An Uncommon Severe Relapse of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody (MPO-ANCA) Vasculitis
por: Araújo, Tiago, et al.
Publicado: (2021)

MPO-ANCA-associated vasculitis in the context of autoimmune polyglandular syndrome type 3: case report and literature review
por: Dikovec, Cédric, et al.
Publicado: (2022)

ANCA-Positive Patients: The Influence of PR3 and MPO Antibodies on Survival Rate and The Association with Clinical and Laboratory Characteristics
por: Drooger, J.C, et al.
Publicado: (2009)

Rhinologic and sinonasal changes in PR3 ANCA pulmonary vasculitis
por: Zycinska, K, et al.
Publicado: (2010)

Avacopan improves patient perspective on steroid-related toxicity effects in a case with ANCA-associated vasculitis
por: Korsten, Peter, et al.
Publicado: (2023)

Membranous Nephropathy With MPO-ANCA-Associated Crescentic GN
por: Kanodia, Kamal, et al.
Publicado: (2014)

MPO-C-ANCA-associated necrotising and crescentic glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qur2ntnq4a39n8dpo6s5k1p397